Compare Barrick Gold Corp (B) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barrick Gold Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Barrick Gold Corp trades at $40.75 (market cap $65.92B), while State Street SPDR S&P Biotech ETF trades at $158.26. The key difference: Barrick Gold Corp pays a 1.74% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Barrick Gold Corp nearer its low. Which is the better fit depends on your goals.
| B | XBI | |
|---|---|---|
Market Cap | $65.92B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $52.97 | $164.28 |
52-Week Low | $23.50 | $86.92 |
Enterprise Value | $64.67B | — |
Dividend Yield | 1.74% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barrick Gold Corp
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
